WO1999059541A3 - Preparations de cyclosporine - Google Patents
Preparations de cyclosporine Download PDFInfo
- Publication number
- WO1999059541A3 WO1999059541A3 PCT/EP1999/003002 EP9903002W WO9959541A3 WO 1999059541 A3 WO1999059541 A3 WO 1999059541A3 EP 9903002 W EP9903002 W EP 9903002W WO 9959541 A3 WO9959541 A3 WO 9959541A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cyclosporin
- preparations
- solid
- cyclosporin preparations
- presented
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5169—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99922158A EP1077676A2 (fr) | 1998-05-15 | 1999-05-04 | Preparations de cyclosporine |
AU39303/99A AU3930399A (en) | 1998-05-15 | 1999-05-04 | Cyclosporin preparations |
CA002332270A CA2332270A1 (fr) | 1998-05-15 | 1999-05-04 | Preparations de cyclosporine |
JP2000549206A JP2002515415A (ja) | 1998-05-15 | 1999-05-04 | シクロスポリン製剤 |
NO20005769A NO20005769D0 (no) | 1998-05-15 | 2000-11-14 | Cyklosporinderivater |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19821951A DE19821951A1 (de) | 1998-05-15 | 1998-05-15 | Cyclosporin-Zubereitungen |
DE19821951.2 | 1998-05-15 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999059541A2 WO1999059541A2 (fr) | 1999-11-25 |
WO1999059541A3 true WO1999059541A3 (fr) | 2000-01-20 |
Family
ID=7867961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1999/003002 WO1999059541A2 (fr) | 1998-05-15 | 1999-05-04 | Preparations de cyclosporine |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1077676A2 (fr) |
JP (1) | JP2002515415A (fr) |
CN (1) | CN1301171A (fr) |
AU (1) | AU3930399A (fr) |
CA (1) | CA2332270A1 (fr) |
DE (1) | DE19821951A1 (fr) |
NO (1) | NO20005769D0 (fr) |
WO (1) | WO1999059541A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9920558D0 (en) * | 1999-08-31 | 1999-11-03 | Bradford Particle Design Ltd | Methods for particle formation and their products |
GB2381453A (en) * | 1999-08-31 | 2003-05-07 | Bradford Particle Design Ltd | Active/polymer coformulations |
US20020034525A1 (en) | 2000-06-30 | 2002-03-21 | Kao Corporation | Skin cosmetic composition |
PT2079456E (pt) * | 2007-04-04 | 2013-03-13 | Sigmoid Pharma Ltd | Composições farmacêuticas de ciclosporina |
JP6627380B2 (ja) * | 2015-09-30 | 2020-01-08 | ユーハ味覚糖株式会社 | アスコルビン酸もしくはアスコルビン酸誘導体の浸透性を向上させたナノ粒子分散液 |
CN106173799B (zh) * | 2016-07-08 | 2019-08-16 | 武汉轻工大学 | 纳他霉素微乳液及其制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992018105A1 (fr) * | 1991-04-19 | 1992-10-29 | Sandoz Ltd. | Perfectionnements apportes aux compositions pharmaceutiques |
WO1993013753A1 (fr) * | 1992-01-17 | 1993-07-22 | Alfatec-Pharma Gmbh | Comprimes contenant des medicaments peptidiques, leur fabrication et leur application |
WO1996014079A1 (fr) * | 1994-11-03 | 1996-05-17 | Arzneimittelwerk Dresden Gmbh | Nouvelles formes de preparations de cycylosporines pour administration par voie orale, de composition simple et haute biodisponibilite, et leur procede de production |
WO1996022103A1 (fr) * | 1995-01-21 | 1996-07-25 | Cheil Foods & Chemicals, Inc. | Formulations solides pour l'administration de cyclosporine a par voie orale |
WO1996031202A1 (fr) * | 1995-04-03 | 1996-10-10 | Elan Corporation, Plc | Microspheres et nanospheres biodegradables a liberation lente renfermant de la cyclosporine |
WO1997035603A1 (fr) * | 1996-03-25 | 1997-10-02 | Sangstat Medical Corporation | Formulations de cyclosporine a sous forme de nanoparticules |
-
1998
- 1998-05-15 DE DE19821951A patent/DE19821951A1/de not_active Withdrawn
-
1999
- 1999-05-04 CA CA002332270A patent/CA2332270A1/fr not_active Abandoned
- 1999-05-04 CN CN99806202A patent/CN1301171A/zh active Pending
- 1999-05-04 WO PCT/EP1999/003002 patent/WO1999059541A2/fr not_active Application Discontinuation
- 1999-05-04 AU AU39303/99A patent/AU3930399A/en not_active Abandoned
- 1999-05-04 EP EP99922158A patent/EP1077676A2/fr not_active Withdrawn
- 1999-05-04 JP JP2000549206A patent/JP2002515415A/ja not_active Withdrawn
-
2000
- 2000-11-14 NO NO20005769A patent/NO20005769D0/no not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992018105A1 (fr) * | 1991-04-19 | 1992-10-29 | Sandoz Ltd. | Perfectionnements apportes aux compositions pharmaceutiques |
WO1993013753A1 (fr) * | 1992-01-17 | 1993-07-22 | Alfatec-Pharma Gmbh | Comprimes contenant des medicaments peptidiques, leur fabrication et leur application |
WO1996014079A1 (fr) * | 1994-11-03 | 1996-05-17 | Arzneimittelwerk Dresden Gmbh | Nouvelles formes de preparations de cycylosporines pour administration par voie orale, de composition simple et haute biodisponibilite, et leur procede de production |
WO1996022103A1 (fr) * | 1995-01-21 | 1996-07-25 | Cheil Foods & Chemicals, Inc. | Formulations solides pour l'administration de cyclosporine a par voie orale |
WO1996031202A1 (fr) * | 1995-04-03 | 1996-10-10 | Elan Corporation, Plc | Microspheres et nanospheres biodegradables a liberation lente renfermant de la cyclosporine |
WO1997035603A1 (fr) * | 1996-03-25 | 1997-10-02 | Sangstat Medical Corporation | Formulations de cyclosporine a sous forme de nanoparticules |
Also Published As
Publication number | Publication date |
---|---|
CA2332270A1 (fr) | 1999-11-25 |
CN1301171A (zh) | 2001-06-27 |
DE19821951A1 (de) | 1999-11-18 |
JP2002515415A (ja) | 2002-05-28 |
EP1077676A2 (fr) | 2001-02-28 |
WO1999059541A2 (fr) | 1999-11-25 |
NO20005769L (no) | 2000-11-14 |
NO20005769D0 (no) | 2000-11-14 |
AU3930399A (en) | 1999-12-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1211397A (en) | Shampoo composition containing capsules or particles | |
AU3136897A (en) | Compositions, methods and devices for the transdermal delivery of drugs | |
AU4151099A (en) | Cosmetic or dermopharmaceutical composition in the form of beads and methods forpreparing same | |
CA2294783A1 (fr) | Compositions pharmaceutiques administrables par voie orale, comprenant une substance active et une cyclodextrine | |
AU6076198A (en) | Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers | |
AU6190298A (en) | Liquid antacid compositions | |
AU1800600A (en) | Ume extract having medicinal effects and compositions containing the same | |
IL116746A0 (en) | Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions | |
ZA983849B (en) | Pharmaceutical compositions of tizoxanide and nitazoxanide. | |
AU2543399A (en) | Anticonvulsant drugs and pharmaceutical compositions thereof | |
AU1067599A (en) | Peptide compositions for the treatment and prevention of hiv infection | |
AU7497798A (en) | 3-epi compounds of vitamin d3 and uses thereof | |
WO1999059541A3 (fr) | Preparations de cyclosporine | |
HK1042424A1 (en) | Preparations containing virus-like particles as immunopotentiators administered through the mucosa | |
CA2284142A1 (fr) | Compositions contenant des acides lysophosphotidiques inhibant l'apoptose, et leurs utilisations | |
AU2002358418A1 (en) | Pharmaceutical preparation containing micro-encapsulated or nano-encapsulated ginsenosides | |
AU4218400A (en) | Lyophilized solid dosage forms and methods of making | |
CA2348474A1 (fr) | Composition d'une substance pharmaceutiquement active et dispositif de distribution | |
IL116828A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
HK1025907A1 (en) | Pharmaceutical compositions of tizoxanide and nitazoxanide. | |
IL116745A0 (en) | Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions | |
AU3300297A (en) | Laminin-5 and the formation of basement membrane structure | |
AU2002252981A1 (en) | Pharmaceutical compositions containing beta-mimetic agents and having few side-effects | |
AU5072000A (en) | Pharmaceutical composition for nasally administering water-soluble active substances | |
AUPP307398A0 (en) | Fluid pump and actuating system incorporating piezoceramic elements |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 99806202.2 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AU BG BR BY CA CN CZ GE HU ID IL IN JP KR KZ LT LV MK MX NO NZ PL RO RU SG SI SK TR UA US ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AU BG BR BY CA CN CZ GE HU ID IL IN JP KR KZ LT LV MK MX NO NZ PL RO RU SG SI SK TR UA US ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999922158 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09674923 Country of ref document: US |
|
ENP | Entry into the national phase |
Ref document number: 2332270 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 1999922158 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999922158 Country of ref document: EP |